Patents by Inventor Alain Sanson

Alain Sanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9758552
    Abstract: A ligand recombinant protein inhibiting HB-EGF (Heparin-Binding Epidermal Growth Factor like), from the R domain of diphtheria toxin, which can be used for the treatment and diagnosis of diseases involving the activation of the HB-EGF/EGFR pathway.
    Type: Grant
    Filed: March 19, 2013
    Date of Patent: September 12, 2017
    Assignee: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Daniel Gillet, Benoit Villiers, Sylvain Pichard, Bernard Maillere, Alain Sanson
  • Publication number: 20150051146
    Abstract: A ligand recombinant protein inhibiting HB-EGF (Heparin-Binding Epidermal Growth Factor like), from the R domain of diphtheria toxin, which can be used for the treatment and diagnosis of diseases involving the activation of the HB-EGF/EGFR pathway.
    Type: Application
    Filed: March 19, 2013
    Publication date: February 19, 2015
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALT
    Inventors: Daniel Gillet, Benoit Villiers, Sylvain Pichard, Bernard Maillere, Alain Sanson
  • Patent number: 7919455
    Abstract: The present invention relates to a peptide labelled with fluorine-18 for the specific recognition of lipid vectors.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: April 5, 2011
    Assignees: Commissariat a l'Energie Atomique, Universite Pierre et Marie Curie (Paris VI)
    Inventors: Alain Sanson, Francoise Ochsenbein, Frederic Dolle
  • Patent number: 7851440
    Abstract: The present invention relates to a peptide for the specific recognition of lipid vectors.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: December 14, 2010
    Assignees: Commissariat a l'Energie Atomique, Universite Pierre et Marie Curie (Paris VI)
    Inventors: Alain Sanson, Francoise Ochsenbein
  • Publication number: 20060233706
    Abstract: The present invention relates to a peptide labelled with fluorine-18 for the specific recognition of lipid vectors.
    Type: Application
    Filed: June 30, 2003
    Publication date: October 19, 2006
    Applicants: COMMISSARIAT A L'ENERGIE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS VI)
    Inventors: Alain Sanson, Francoise Ochsenbein, Frederic Dolle
  • Publication number: 20060148689
    Abstract: The present invention relates to a peptide for the specific recognition of lipid vectors.
    Type: Application
    Filed: June 30, 2003
    Publication date: July 6, 2006
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE, UNIVERSITE PIERRE ET MARIE CURIE
    Inventors: Alain Sanson, Francoise Ochsenbein
  • Patent number: 6979554
    Abstract: The present invention relates to a compound having affinity for a negatively charged phospholipid as well as to a detection molecule, to a conjugate and to a pharmaceutical composition comprising said compound. Generally speaking, the compound of the present invention is useful for specific recognition of lipid vectors. It may be used in engineering and in the generation of compound for recognizing and sequestrating of negatively charged lipids, such as phosphatidyl-serine and phosphatidic acid. The chemical structure of the present invention may have the construction (I).
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: December 27, 2005
    Assignees: Commissariat a l'Energie Atomique, Universite Pierre et Marie Curie (Paris VI)
    Inventors: Alain Sanson, Françoise Russo-Marie, Jean-Michel Neumann, Françoise Cordier-Ochsenbein, Raphael Guerois